Ocugen, Inc. (OCGN)
1.94
-0.01
(-0.51%)
USD |
NASDAQ |
Apr 16, 16:00
1.92
-0.02
(-1.03%)
After-Hours: 20:00
Ocugen Cash from Investing (Quarterly) : -0.035M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| REGENXBIO, Inc. | 37.54M |
| Krystal Biotech, Inc. | 11.16M |
| Phathom Pharmaceuticals, Inc. | -0.087M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| MannKind Corp. | -291.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.96M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow | -57.15M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -14.18M |
| Free Cash Flow to Firm (Quarterly) | -12.66M |
| Free Cash Flow Yield | -9.82% |